4167 松瑞藥歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 38.23% | 24.44% | -5.27% | -5.27% |
| 2025Q1 | 36.86% | 10.14% | 145.96% | 145.96% |
| 2024Q4 | 29.60% | 6.23% | 16.89% | 16.53% |
| 2024Q3 | 37.32% | 22.24% | 12.62% | 12.62% |
| 2024Q2 | 24.94% | 8.85% | 5.99% | 5.99% |
| 2024Q1 | 20.74% | -1.22% | 26.92% | 26.92% |
| 2023Q4 | 41.65% | 24.91% | 13.65% | 13.64% |
| 2023Q3 | 2.27% | -17.08% | -5.91% | -5.91% |
| 2023Q2 | 12.91% | -12.85% | 2.10% | 2.10% |
| 2023Q1 | 23.97% | -1.76% | -1.60% | -1.60% |
| 2022Q4 | 11.94% | -8.15% | -16.05% | -16.05% |
| 2022Q3 | 12.77% | -3.46% | 38.11% | 38.11% |
| 2022Q2 | 14.75% | -0.82% | -0.43% | -0.43% |
| 2022Q1 | 1.20% | -19.06% | -17.58% | -17.58% |
| 2021Q4 | 8.00% | -8.00% | -8.77% | -8.77% |
| 2021Q3 | 4.01% | -16.75% | -15.00% | -15.00% |
| 2021Q2 | 21.22% | 6.58% | 3.09% | 3.09% |
| 2021Q1 | 30.58% | 16.84% | 15.81% | 15.81% |
| 2020Q4 | 33.65% | 18.98% | 16.14% | 16.14% |
| 2020Q3 | 30.61% | 14.09% | 10.49% | 10.49% |
| 2020Q2 | 26.97% | 8.64% | 5.72% | 5.72% |